MedTrace Logo

A RCT Study in Schizophrenia Relapse Prevention

NCT01885923 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2013-07-12

No results posted yet for this study

Summary

THE AIM OF THE PROJECT The main aim lies in the prevention of frequent relapses typical for schizophrenia and schizoaffective disorder by means of simple, highly cost-effective information technology-aided approach RESEARCH HYPOTHESIS A the end of 18 months study duration, patients in the active group enrolled in ITAREPS will demonstrate statistically significantly reduced risk of hospitalization, decreased number of hospitalization days and reduced direct inpatient costs in comparison to control group not using the program.

Conditions

  • Relapse Schizophrenia

Interventions

DEVICE

ITAREPS

Program ITAREPS (Information Technology Aided Relaps Prevention in Schizophrenia)

Sponsors & Collaborators

  • Prague Psychiatric Center

    lead OTHER_GOV

Principal Investigators

  • Filip Spaniel, MD, PhD · Prague Psychiatric Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2014-07-31
Completion
2015-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01885923 on ClinicalTrials.gov